Valiant Organics Reports Q2 FY26 Results; Extends Shri Sathiababu K. Kallada as Managing Director

<h1>Valiant Organics Reports Q2 FY26 Results; Extends Shri Sathiababu K. Kallada as Managing Director</h1>

Valiant Organics Limited reported its unaudited financial results for the quarter ended June 30, 2026. The company announced that the Board of Directors approved these results, which included an overview of both standalone and consolidated performance metrics. Additionally, the company confirmed the re-appointment of Shri Sathiababu K. Kallada as a Managing Director.

The results for the quarter showed figures reflecting strong operational activity across the group entities. The management has also indicated that Pharma Business has been identified as an additional reportable segment alongside Specialty Chemicals.

Financial Performance Snapshot​

Valiant Organics presented its financial performance through both standalone and consolidated statements, which were reviewed by the company's Audit Committee. The results reflect a diversified operational structure, with segments including Specialty Chemical Division and Pharma Division.

Key takeaways from the unaudited standalone results for the quarter ended June 30, 2026 are summarized below:


The consolidated figures reflected across all entities of the group showed slightly higher overall income and profit before tax:


The company reported that one of its subsidiaries had a negligible total revenue from operations and consequently incurred a net loss after tax during the quarter.

Management and Operational Updates​

Regarding leadership appointments, Valiant Organics confirmed the re-appointment of Shri Sathiababu K. Kallada as Managing Director of the Company. The appointment is set to be effective for three consecutive years, from May 24, 2027 to May 23, 2030, and is subject to the approval of the Shareholders at the ensuing Annual General Meeting. Shri Sathiababu K. Kallada holds a Bachelor of Science degree and possesses over 38 years of experience in the Chemical Industry. He was also noted as not being related to any other Director of the Company.

In terms of corporate structure, the company made several operational announcements:

• Registered Office Relocation: The registered office is shifting from 109, 1st Floor, Udyog Kshetra, Mulund Goregaon Link Road, Mulund (W), to Plot No. M-7, MIDC, Tarapur, Boisar, Palghar 401506, Maharashtra. This move involves a jurisdiction change from the Registrar of Companies, Mumbai I, to the Registrar of Companies, Mumbai II (headquartered at Navi-Mumbai).
• Corporate Office Location: The corporate office is currently located at 701-A, Tower-B, Embassy 247 Park, Gandhi Nagar, Vikhroli (West), Mumbai - 400083, Maharashtra.

Segment Analysis and Transactions​

The company operates across multiple entities, including subsidiaries such as Valiant Speciality Chemical Limited and Dhanvallabh Ventures LLP, along with associates like Valiant Laboratories Limited.

Operational activity details for the quarter included:

• Employee Stock Options: The company allotted 15,000 equity shares to eligible employees on June 22, 2026, pursuant to the Valiant Employees Stock Option Plan, 2022. Earlier, 15,000 equity shares were allotted during the quarter ended December 31, 2025.
• Related Party Agreement: The company entered into a Conducting cum Loan & License Agreement with Aarti Pharmalabs Ltd for conducting manufacturing operations on behalf of Aarti Pharmalabs Limited at its AJ4 division, effective from May 15, 2025.
• Insurance Claim: Valiant Organics received Rs. 852.76 lakhs towards a fire insurance claim settlement relating to the Sarigam Division fire incident in FY 2022-23, with Rs. 572.08 lakhs recognized under Exceptional Items during the period.

VALIANTORG Stock Price Movement​

On Wednesday, shares of Valiant Organics Limited climbed to close at ₹325.30, marking a 4.99% gain over the previous session’s close. The stock saw considerable activity, with 165,655 shares traded throughout the day.